Till Assmann

Summary

Affiliation: Heinrich Heine University
Country: Germany

Publications

  1. ncbi Applications of tacrolimus for the treatment of skin disorders
    T Assmann
    Department of Dermatology, University of Dusseldorf, Moorenstr 5, D 40225, Dusseldorf, Germany
    Immunopharmacology 47:203-13. 2000
  2. ncbi Topical tacrolimus for the treatment of inflammatory skin diseases
    T Assmann
    Department of Dermatology, Heinrich Heine University, Duesseldorf, Germany
    Expert Opin Pharmacother 2:1167-75. 2001
  3. ncbi New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications
    Till Assmann
    Department of Dermatology, University of Dusseldorf, Dusseldorf, Germany
    Clin Dermatol 20:505-14. 2002
  4. ncbi Potential future dermatological indications for tacrolimus ointment
    Thomas Ruzicka
    Department of Dermatology, , Moorenstr 5, , Germsny
    Eur J Dermatol 13:331-42. 2003
  5. ncbi Tacrolimus ointment for the treatment of vulvar lichen sclerosus
    Till Assmann
    Department of Dermatology, Heinrich-Heine-University, Duesseldorf, Germany
    J Am Acad Dermatol 48:935-7. 2003
  6. ncbi CCL27-CCR10 interactions regulate T cell-mediated skin inflammation
    Bernhard Homey
    DNAX Research Institute, Palo Alto, California, USA
    Nat Med 8:157-65. 2002
  7. ncbi Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease
    Heidi Plettenberg
    Arch Dermatol 139:651-4. 2003

Detail Information

Publications7

  1. ncbi Applications of tacrolimus for the treatment of skin disorders
    T Assmann
    Department of Dermatology, University of Dusseldorf, Moorenstr 5, D 40225, Dusseldorf, Germany
    Immunopharmacology 47:203-13. 2000
    ..The aim of this review is to summarize the current knowledge regarding the pharmacokinetic properties, adverse effects and therapeutic indications of tacrolimus in dermatology...
  2. ncbi Topical tacrolimus for the treatment of inflammatory skin diseases
    T Assmann
    Department of Dermatology, Heinrich Heine University, Duesseldorf, Germany
    Expert Opin Pharmacother 2:1167-75. 2001
    ....
  3. ncbi New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications
    Till Assmann
    Department of Dermatology, University of Dusseldorf, Dusseldorf, Germany
    Clin Dermatol 20:505-14. 2002
  4. ncbi Potential future dermatological indications for tacrolimus ointment
    Thomas Ruzicka
    Department of Dermatology, , Moorenstr 5, , Germsny
    Eur J Dermatol 13:331-42. 2003
    ..It also provides recommendations for future clinical studies with tacrolimus ointment...
  5. ncbi Tacrolimus ointment for the treatment of vulvar lichen sclerosus
    Till Assmann
    Department of Dermatology, Heinrich-Heine-University, Duesseldorf, Germany
    J Am Acad Dermatol 48:935-7. 2003
    ..1% (Protopic) twice daily, signs and symptoms of lichen sclerosus resolved. To our knowledge, this is the first report of the use of topical tacrolimus, which does not induce skin atrophy, in the treatment of vulvar lichen sclerosus...
  6. ncbi CCL27-CCR10 interactions regulate T cell-mediated skin inflammation
    Bernhard Homey
    DNAX Research Institute, Palo Alto, California, USA
    Nat Med 8:157-65. 2002
    ..Together, these findings indicate that CCL27-CCR10 interactions have a pivotal role in T cell-mediated skin inflammation...
  7. ncbi Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease
    Heidi Plettenberg
    Arch Dermatol 139:651-4. 2003